Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene

By Gomes Aldrin V.   Potter James D.  

Molecular and Cellular Biochemistry, Vol. 263, Iss. 1, 2004-08 ,pp. : 99-114

Springer Publishing Company

Access to resources Recommend Favorite

Mutations in &bgr;-Myosin S2 that cause Familial Hypertrophic Cardiomyopathy (FHC) Abolish the Interaction with the Regulatory Domain of Myosin-binding Protein-C

By Gruen M.   Gautel M.  

Journal of Molecular Biology, Vol. 286, Iss. 3, 1999-02 ,pp. : 933-949

Academic Press

Access to resources Recommend Favorite

Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy

By Zou Yubao  

Molecular Biology Reports, Vol. 40, Iss. 6, 2013-06 ,pp. : 3969-3976

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of MYH-associated polyposis related to three recurrent mutations in Morocco

By Laarabi F. Z.   Cherkaoui Jaouad I.   Benazzouz A.   Squalli D.   Sefiani A.  

Annals of Human Biology, Vol. 38, Iss. 3, 2011-05 ,pp. : 360-363

Informa Healthcare

Access to resources Recommend Favorite

A mouse model of familial hypertrophic cardiomyopathy caused by a -tropomyosin mutation

By Prabhakar R.   Petrashevskaya N.   Schwartz A.   Aronow B.   Boivin G.P.   Molkentin J.D.   Wieczorek D.F.  

Molecular and Cellular Biochemistry, Vol. 251, Iss. 1-2, 2003-09 ,pp. : 33-42

Springer Publishing Company

Access to resources Recommend Favorite